Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesMesa Laboratories Inc

Mesa Laboratories Inc

Technology Scientific & Technical Instruments
PortfolioPortfolio WatchlistWatchlist
Company price
139.21 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
183742
Market Cap
711.51M
P/E
142.87

Momentum Score

…

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
137.38
Low
142.93
High
52 Week Price Range
63.07
Low
132.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
139.21
Dividend Yield
0.53%
Revenue TTM
249.72M
Revenue Per Share
44.90
Gross Profit TTM
160.34M
Debt / Equity
0.91
ROE
2.66%
Net Debt
141.90M
ROCE
3.28%
Diluted EPS TTM
0.89

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 12.01M 5.96M -275.65M -0.39M 3.57M
Net income 6.71M -1.97M -254.25M 0.93M 1.87M
Selling general administrative 78.66M 73.33M 72.87M 72.44M 60.31M
Selling and marketing expenses 40.79M 41.68M 38.62M 37.44M 28.31M
Gross profit 158.27M 150.87M 133.25M 133.69M 109.09M
Reconciled depreciation 23.27M 24.53M 31.57M 33.82M 25.07M
Ebit 12.01M 17.82M -269.95M -30.50M -20.37M
Ebitda 35.28M 42.35M -238.38M 3.32M 4.70M
Depreciation and amortization 23.27M 24.53M 31.57M 33.82M 25.07M
Non operating income net other - - - 1.06M -
Operating income 18.51M 16.34M -272.07M -30.50M -20.37M
Other operating expenses 230.62M 224.64M 488.26M 215.76M 179.63M
Interest expense 10.69M 11.86M 5.70M 3.71M 3.88M
Tax provision 5.30M 7.93M -21.40M -1.32M 1.70M
Net interest income -10.69M -11.86M -5.70M -4.77M -3.88M
Income tax expense 5.30M 7.93M -21.40M -1.32M 1.70M
Total revenue 249.13M 240.98M 216.19M 219.08M 184.34M
Total operating expenses 139.76M 134.53M 405.32M 130.37M 104.39M
Cost of revenue 90.86M 90.11M 82.94M 85.39M 75.25M
Total other income expense net -6.50M -10.38M -3.57M 30.11M 23.94M
Net income from continuing ops 6.71M -1.97M -254.25M 0.93M 1.87M
Net income applicable to common shares - - - 0.93M 1.87M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 427.75M 433.35M 446.80M 661.83M 707.37M
Intangible assets 83.35M 96.88M 113.75M 18.23M 250.12M
Other current assets 8.87M 8.03M 9.41M 86.06M 74.97M
Total liab 241.50M 273.52M 301.40M 268.35M 313.57M
Total stockholder equity 186.25M 159.83M 145.39M 393.48M 393.80M
Deferred long term liab - - - 34.03M -
Other current liab 32.94M 28.31M 18.19M 19.95M 22.81M
Common stock 375.35M 358.54M 343.64M 332.08M 313.46M
Capital stock 375.35M 358.54M 343.64M 332.08M 313.46M
Retained earnings -185.75M -188.94M -183.49M 74.20M 76.67M
Other liab - - - 35.97M 39.71M
Good will 186.86M 181.76M 180.10M 286.44M 291.17M
Other assets - - 0.00M 2.76M 554.43M
Cash 26.93M 27.32M 28.21M 32.91M 49.35M
Total current liabilities 61.90M 163.96M 44.31M 43.36M 48.05M
Current deferred revenue 14.72M 14.71M 15.48M 14.41M 14.58M
Net debt 141.90M 154.15M 203.08M 137.36M 171.79M
Short term debt 9.31M 104.57M 2.99M 2.87M 2.77M
Short long term debt 5.62M 101.05M - - -
Short long term debt total 168.83M 181.47M 231.30M 170.27M 221.13M
Other stockholder equity - - -0.00M -12.79M 323.13M
Property plant equipment - - - 28.15M 28.62M
Total current assets 106.27M 102.69M 109.35M 118.97M 124.32M
Net tangible assets - - - 107.04M 393.80M
Net receivables 44.10M 41.97M 39.05M 42.55M 41.22M
Long term debt 145.86M 76.90M 221.70M 183.27M 218.37M
Inventory 26.37M 25.36M 32.67M 34.64M 24.61M
Accounts payable 4.93M 5.75M 6.04M 6.13M 7.90M
Accumulated other comprehensive income -3.36M -9.78M -14.76M -12.79M 3.67M
Common stock total equity - - - 332.08M -
Retained earnings total equity - - - 74.20M -
Non currrent assets other 1.66M 18.32M 0.87M 208.96M 11.83M
Non current assets total 321.48M 330.66M 337.44M 542.86M 583.05M
Capital lease obligations 3.69M 3.52M 2.99M 2.87M 2.77M
Long term debt total - - - 183.27M -
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -4.50M -81.31M -9.49M -305.23M
Change to liabilities - - - -4.91M 3.96M
Total cashflows from investing activities -3.25M -4.50M -81.31M -9.49M -305.23M
Net borrowings -26.75M -42.35M 37.50M -36.00M 49.00M
Total cash from financing activities -41.85M -44.51M 32.84M -33.33M 52.58M
Change to operating activities - - - -3.87M -3.35M
Net income 6.71M -1.97M -254.25M 0.93M 1.87M
Change in cash -0.39M -0.89M -4.70M -16.44M -214.52M
Begin period cash flow 27.32M 28.21M 32.91M 49.35M 263.87M
End period cash flow 26.93M 27.32M 28.21M 32.91M 49.35M
Total cash from operating activities 42.83M 46.81M 44.13M 27.98M 39.22M
Issuance of capital stock - - - 0.00M 0.00M
Depreciation 23.27M 24.53M 31.57M 33.82M 25.07M
Other cashflows from investing activities -3.25M -0.25M - -4.95M -
Dividends paid 3.52M 3.47M 3.45M 3.41M 3.34M
Change to inventory -4.43M 1.15M 2.56M -10.18M -1.04M
Change to account receivables -3.21M -2.92M 4.94M -2.12M -6.75M
Sale purchase of stock - - -0.73M 7.00M -0.88M
Other cashflows from financing activities -11.58M 1.30M -1.22M 6.08M 76.92M
Change to netincome - - - 10.34M 19.48M
Capital expenditures 3.25M 4.50M 2.57M 4.54M 4.43M
Change receivables - - - -2.12M -
Cash flows other operating - - - 1.03M -
Cash and cash equivalents changes - - - -14.84M -
Change in working capital -4.99M 6.90M 5.97M -17.11M -7.19M
Stock based compensation 17.87M 13.14M 11.94M 12.54M 11.39M
Other non cash items 1.26M 4.28M 277.32M 1.30M 7.96M
Free cash flow 39.58M 42.31M 41.57M 23.44M 34.79M

Peer Comparison*

Sector: Technology Industry: Scientific & Technical Instruments

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MLAB
Mesa Laboratories Inc		 -
-%		 139.21 142.87 35.21 2.85 3.60 3.18 18.40
KYCCF
Keyence		 -1.77
0.38%		 470.00 41.66 38.76 0.11 5.69 0.10 0.19
COHR
Coherent Corp		 19.90
9.27%		 234.56 333.78 46.73 10.24 7.63 10.78 62.92
GRMN
Garmin Ltd		 -
-%		 293.93 28.91 24.45 7.01 5.99 6.72 22.32
KEYS
Keysight Technologies Inc		 14.18
4.87%		 305.64 42.58 20.00 8.11 8.16 8.17 28.06

Profile*

Mesa Laboratories Inc

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

12100 West Sixth Avenue, Lakewood, CO, United States, 80228

303 987 8000

https://www.mesalabs.com

717

Name Title Year Born
Mr. Gary M. Owens CEO, Pres & Director 1968
Mr. John V. Sakys VP, CFO & Chief Accounting Officer 1969
Mr. Brian David Archbold Sr. VP of Continuous Improvement 1976
Mr. Bryan T. Leo Sr. VP of Operations NA
Mr. Garrett Krushefski Sr. VP of Operations NA
Mr. Peter M. Dansky Pres of Clinical Genomics 1961
Mr. Gary M. Owens CEO, President & Director 1968
Mr. Brian David Archbold Senior Vice President of Continuous Improvement 1976
Mr. John V. Sakys CPA VP & CFO 1969
Mr. Brian David Archbold Senior Vice President of Operations & Continuous Improvement 1975

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…